-
Nov 9, 2021, 15:53 PM
by
Full story
-
Nov 9, 2021, 15:53 PM
by
VisualDx has announced a new collaboration with Janssen Biotech, Inc., in which Janssen will leverage VisualDx’s API to improve diagnostic accuracy.
Full story
-
Nov 9, 2021, 15:53 PM
by
• Integrated calibration tools facilitate multi-parameter calibration across all lab systems
• Added new features to control test plan progression broaden support for process safety and battery testing labs
Full story
-
Nov 9, 2021, 15:51 PM
by
Rousselot®, the Health brand of Darling Ingredients and the global leader of collagen-based solutions launches Quali-Pure™, a range of gelatins for biomedical applications with controlled endotoxin levels. The latest addition to Rousselot Biomedical’s rapidly expanding portfolio, Quali-Pure, has been specifically designed for a variety of applications including embolization, wound healing, drug delivery, vaccines and hemostatics.
Full story
-
Nov 9, 2021, 15:51 PM
by
EVID AI is the only healthcare literature database that uses machine learning to produce more than 80 million data points ─ from pre-clinical, clinical, economic, epidemiology, patient reported outcomes and review focus areas ─ and allows users to filter search results to only the most relevant, current information needed for further analysis.
Full story
-
Nov 9, 2021, 15:51 PM
by
Curebase, Checkable Medical Announce Joint Clinical Trial to Assess Effectiveness of At-home Strep Test Kit
Full story
-
Nov 9, 2021, 15:51 PM
by
Full story
-
Nov 9, 2021, 15:51 PM
by
Full story
-
Nov 9, 2021, 15:51 PM
by
Open Health Network (OHN) announces the launch of PatientSphere 2.0 for Cardiology, an online system that connects a team of diverse providers to tightly coordinate care for patients with chronic heart conditions. The system offers an evidence-based approach to the real-time integration of every aspect of chronic cardiology care, delivering improved patient outcomes and reducing complexity costs. PatientSphere 2.0 for Cardiology incorporates all the capabilities of its predecessors, PatientSphere and Constant Care. The system also can be modified to support research, clinical and prevention applications in many other indications, both common and rare diseases, including cancer, gastrointestinal disease, diabetes, asthma and sickle cell disease.
Full story
-
Nov 9, 2021, 15:51 PM
by
STEMart launches medical device irritation testing service following the biocompatibility guidelines modified for medical devices.
Full story
-
Nov 9, 2021, 15:51 PM
by
Amerigo Scientific introduces PNGase F for life science researchers.
Full story
-
Nov 9, 2021, 15:51 PM
by
Torx Software Limited announces the release of Torx Test™ and Torx Analyze™ to complete the Torx platform for small molecule discovery chemistry.
Full story
-
Nov 9, 2021, 15:51 PM
by
Verana Health Launches Population Health Data Engine to Accelerate Clinical Research, Advance Medical Care, and Improve Patient Outcomes
Full story
-
Nov 9, 2021, 15:51 PM
by
Leading global pharmaceutical company presented Pangaea Data’s Novel AI to Automatically Generate Textual Clinical Narratives for Regulatory Reports
Full story
-
Nov 9, 2021, 15:50 PM
by
Full story
-
Nov 9, 2021, 15:50 PM
by
Full story
-
Nov 9, 2021, 15:49 PM
by
Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services category
Full story
-
Nov 9, 2021, 15:49 PM
by
Full story
-
Nov 9, 2021, 15:49 PM
by
Full story
-
Nov 9, 2021, 15:48 PM
by
Rho, a full-service contract research organization (CRO), is showcasing its clinical development expertise during the 12th Annual CNS Summit, taking place at the Encore Boston Harbor Hotel from November 7-10, 2021.
Rho’s Chief Medical Officer, Dr. Jack Modell, along with Dr. John Greist and Dr. Thomas Laughren, will present during a Spotlight Session at the Summit. The 50-minute breakout session, titled, “The Seven Essentials of Clinical Development: How to Avoid Shooting Yourself in the Foot” will showcase the speakers’ combined experience in clinical medicine, academic research, regulatory affairs, and development of drugs and medical applications of information technology.
Full story